Pictet Asset Management (UK)’s Rigel Pharmaceuticals RIGL Stock Holding History

Pictet Asset Management (UK)’s Portfolio RIGL Stock Details RIGL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q2	$82K	Buy	+1,900	New	+$71.7K	﹤0.01%	1713

Other funds holding RIGL

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Tamarack Advisers Carlsbad, California $2.12M AUM 58.09% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

RSCM

Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Lord, Abbett & Co Jersey City, New Jersey $30.6B AUM 57.44% 1-Year Est. Return

Pictet Asset Management (UK)'s RIGL Position: Q2 2021 in Review

Pictet Asset Management (UK) opened a new position in Rigel Pharmaceuticals (RIGL) in Q2 2021: 1,900 shares worth $82K. The stake represents ﹤0.01% of the portfolio and ranks #1713 among its holdings.

159 funds tracked by Wall St. Rank hold RIGL as of Q2 2021.

Pictet Asset Management (UK) held 1,900 shares of Rigel Pharmaceuticals worth $82K as of Q2 2021.
Rigel Pharmaceuticals was a new Pictet Asset Management (UK) position in Q2 2021.
Rigel Pharmaceuticals made up ﹤0.01% of Pictet Asset Management (UK)'s portfolio in Q2 2021, its #1713 holding.
159 funds tracked by Wall St. Rank held Rigel Pharmaceuticals as of Q2 2021.

Based on Pictet Asset Management (UK)'s 13F filing for Q2 2021, filed 16 Aug 2021.